Provided by Tiger Trade Technology Pte. Ltd.

Karyopharm Therapeutics

1.88
+0.09005.03%
Post-market: 1.85-0.0300-1.60%19:51 EDT
Volume:1.90M
Turnover:3.46M
Market Cap:42.61M
PE:-0.14
High:1.89
Open:1.77
Low:1.67
Close:1.79
52wk High:10.99
52wk Low:1.24
Shares:22.66M
Float Shares:15.77M
Volume Ratio:0.83
T/O Rate:12.05%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-13.0816
EPS(LYR):-17.9300
ROE:-891.05%
ROA:-47.61%
PB:-0.13
PE(LYR):-0.10

Loading ...

Feb 17, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 15, 2023

Major Issues Report

8-K - Current report
Feb 15, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 09, 2023

Major Issues Report

8-K - Current report
Dec 29, 2022

Correspondence

CORRESP [Cover] - Correspondence
Dec 14, 2022

Major Issues Report

8-K - Current report
Dec 08, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 05, 2022

Major Issues Report

8-K - Current report
Dec 02, 2022

Major Issues Report

8-K - Current report
Nov 03, 2022

Major Issues Report

8-K - Current report
Nov 03, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 04, 2022

Major Issues Report

8-K - Current report
Aug 04, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 28, 2022

Major Issues Report

8-K - Current report
Jun 15, 2022

Major Issues Report

8-K - Current report